NCT00893737 - "Completeness of Response Following Treatment With Treximet™ for Migraine" | Biotech Hunter

Enrollment

147

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Migraine

Interventions

DRUG

sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet)

Treximet 1 tablet as soon as the patient has headache indicative of migraine. May be repeated between 2 and 24 hours post-treatment for persistent or recurring headache. Subjects should not take more than 2 Treximet tablets in 24 hours.

Trial Locations (8)

11803

Island Neurological Associates, PC, Plainview

15236

Preferred Primary Care Physicians, Pittsburgh

38018

Wesley Headache Clinic and Research Center, Cordova

49009

Westside Family Medical Center, Kalamazoo

63141

Mercy Health Research/Ryan Headache Center, St Louis

65807

Clinvest, Springfield

78258

Texas Headache Associates, San Antonio

94109

San Francisco Clinical Research Center, San Francisco